GSK Investigational Site

Vercelli 13100

0 studies enrolling now · 1 studies all time

What they study most

Respiratory Syncytial Virus Infections

Studies at this site

• Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above — Completed